Reviewing Delhaize Group SA (DEG) & Diplomat Pharmacy (DPLO)
Delhaize Group SA (NYSE: DEG) and Diplomat Pharmacy (NYSE:DPLO) are both non-cyclical consumer goods & services companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.
Earnings & Valuation
This table compares Delhaize Group SA and Diplomat Pharmacy’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Delhaize Group SA||N/A||N/A||N/A||$1.19||23.62|
|Diplomat Pharmacy||$4.53 billion||0.30||$70.47 million||$0.17||115.76|
Diplomat Pharmacy has higher revenue and earnings than Delhaize Group SA. Delhaize Group SA is trading at a lower price-to-earnings ratio than Diplomat Pharmacy, indicating that it is currently the more affordable of the two stocks.
This table compares Delhaize Group SA and Diplomat Pharmacy’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Delhaize Group SA||1.77%||7.11%||3.43%|
This is a breakdown of current ratings and target prices for Delhaize Group SA and Diplomat Pharmacy, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Delhaize Group SA||0||0||0||0||N/A|
Diplomat Pharmacy has a consensus target price of $17.89, indicating a potential downside of 9.08%. Given Diplomat Pharmacy’s higher possible upside, analysts plainly believe Diplomat Pharmacy is more favorable than Delhaize Group SA.
Insider & Institutional Ownership
69.9% of Diplomat Pharmacy shares are owned by institutional investors. 35.4% of Diplomat Pharmacy shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Delhaize Group SA pays an annual dividend of $0.35 per share and has a dividend yield of 1.2%. Diplomat Pharmacy does not pay a dividend. Delhaize Group SA pays out 29.4% of its earnings in the form of a dividend.
Risk and Volatility
Delhaize Group SA has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, Diplomat Pharmacy has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500.
Diplomat Pharmacy beats Delhaize Group SA on 8 of the 12 factors compared between the two stocks.
About Delhaize Group SA
Delhaize le Lion de Leeuw BV (Belgium Branch), formerly Delhaize Group SA, is a Belgium-based food retailer. The Company operates through three segments: the United States, including Food Lion and Hannaford banners; Belgium, including Delhaize Le Lion and AD Delhaize banners, and Southeastern Europe (SEE), including Alfa Beta, Mega Image and Shop&Go banners. The Company is principally engaged in the operation of food supermarkets through Company-operated, affiliated and franchised stores. Affiliated stores are with its banners that are operated by independent third parties to whom the Company sells its products at wholesale prices. Its store network also includes other store formats, such as proximity, cash and carry, and specialty stores. The Company has stores located in the United States (Northeast, Southeast and Mid-Atlantic), Belgium, Luxembourg, Greece, Serbia, Romania and Indonesia. The Company operates over 3,510 stores.
About Diplomat Pharmacy
Diplomat Pharmacy, Inc. (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates through specialty pharmacy services segment. The Company’s primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialty infusion therapy, and various other serious and/or long-term conditions. The Company provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups, hospitals and health systems. The Company offers various services, such as specialty drug dispensing, retail specialty services, hospital and health system services, and hub services. The Company’s patient care system is used to coordinate and track patient adherence and safety.
Receive News & Stock Ratings for Delhaize Group SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delhaize Group SA and related stocks with our FREE daily email newsletter.